Synopsys (NASDAQ:SNPS – Get Free Report) was upgraded by equities researchers at BNP Paribas Exane from an “underperform” rating to a “neutral” rating in a research report issued to clients and investors on Thursday, Marketbeat Ratings reports. The firm currently has a $420.00 price target on the semiconductor company’s stock. BNP Paribas Exane’s price objective […]